Venus Remedies gets huge global acclaim with UNICEF GMP approval

Our Bureau

Venus Remedies Limited, a leading global pharmaceutical company, has recently secured Good Manufacturing Practices (GMP) approval from the United Nations International Children’s Emergency Fund (UNICEF). This milestone underscores Venus Remedies’ commitment to delivering top-quality pharmaceutical solutions worldwide. Venus Remedies’ manufacturing unit, located in Baddi, Himachal Pradesh, India, has been recommended […]

Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024

Our Bureau

Galimedix Therapeutics, Inc. (“Galimedix”), a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious eye and brain diseases, announces encouraging data with orally available small molecule GAL-201, showing its neuroprotective and symptomatic alleviation potential in models of Alzheimer’s […]

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Our Bureau

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, announced today that it has opened a new 50,000-square-foot facility in Wuxi, China. This strategic move increases the company’s manufacturing capacity to meet the growing worldwide demand for comprehensive cell analysis solutions. The Wuxi facility offers the advantage of fostering […]

Supply & Demand Chain Executive Names Spinnaker SCA’s Leaders as Recipients of 2024’s Prestigious Pros to Know Award for Lifetime Achievement

Our Bureau

Supply & Demand Chain Executive, the only publication covering the entire global supply chain, named three of Spinnaker SCA’s executives as Lifetime Achievement recipients. John Sharkey, Chief Executive Officer, George Fowler, Chief Technology Officer and Senior Vice President of Planning and Omnichannel, and Joel Garcia, Senior Vice President of Supply Chain Execution, are the winners of this […]

OrthoVentions Invests in Motio[OV] to Develop 3D Printed Implant and Instruments to Treat Joint Arthritis of the Big Toe

Our Bureau

OrthoVentions LLC today announced its investment in MotioOV, an early-stage company created in partnership with the Hospital for Special Surgery (HSS). MotioOV is developing a novel 3D printed implant and custom instruments to address stiffness and pain associated with arthritis of the first metatarsophalangeal (MTP) joint. Under the terms of the […]

No Solution in Sight, Florida Cancer Specialists & Research Institute, Core Ventures Forge Ahead in Race to Recover from Change Healthcare Shutdown

Our Bureau

Weeks following the nationwide outage of Change Healthcare, Florida Cancer Specialists & Research Institute, LLC (FCS) has been able to establish new systems to begin processing claims for prescriptions and medical oncology treatment. With more than $300 million spent each month on medications, Florida’s largest community oncology practice has leveraged existing partnerships to quickly stand-up viable […]

University of South Florida Tampa General Physicians Becomes First Academic Medical Group in the Nation to Achieve Prestigious Collaborative Just Culture® Program Recognition

Our Bureau

Tampa General Hospital (TGH) and USF Health announced this month the University of South Florida Tampa General Physicians (USFTGP) has earned a qualification from global independent certification firm, DNV, for its Collaborative Just Culture Program®. This achievement marks the first recognition of its kind in the nation for an academic medical group and comes less than one […]

Newtopia and Arvest Bank Partner to Prevent, Slow and Reverse Chronic Disease Through Sustainable Habit Change

Our Bureau

Newtopia Inc. (“Newtopia“) (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow and reverse chronic disease, and Arvest Bank (“Arvest“), a leading community-focused bank with more than $27 billion in assets, today announced a partnership to reduce chronic metabolic disease burden among Arvest’s benefited population while helping participants establish healthy […]

Subscribe Now